Impact of Hyperoxia During Cardiopulmonary — CARDIOX

Cardiac Complications Clinical Trial

Official title:
Impact of Hyperoxia During Cardiopulmonary Bypass in the Occurrence of Cardiovascular Complications After Cardiac Surgery

Status Completed

Clinical Trial Summary

The hypothesis implies that this work is the use of hyperoxia during cardiopulmonary bypass by his heart preconditioning effect is associated with a lower incidence of cardiac arrhythmias (atrial fibrillation, tachycardia or ventricular fibrillation) and lesions of myocardial ischemia-reperfusion injury in cardiac surgery postoperative.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02819739
Study type	Interventional
Source	Centre Hospitalier Universitaire, Amiens
Contact
Status	Completed
Phase	Phase 3
Start date	November 11, 2014
Completion date	March 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00747331` - Fenoldopam and Splanchnic Perfusion During Cardiopulmonary Bypass	Phase 4
Recruiting	`NCT00173706` - Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis	Phase 4
Completed	`NCT01916733` - A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study	N/A
Completed	`NCT03211520` - Magnetic Resonance Imaging:A Window to Anthracycline Toxicity
Completed	`NCT03211442` - Implications of MEDIcal Low Dose RADiation Exposure - BReast Cancer Acute Coronary Events